Business
SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development
DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical
About this update from Seastar Medical Holding Corporation
[{"type":"text","content":"DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Thomas R. Mullen as Vice President of Operations and Product Development. Mr. Mullen is a proven medical device professional with 30 years of experience leading business operations, manufacturing, engineering, product development and regulatory remediation. “SeaStar Medical has continued to evolve and remains on a trajectory of growth including near-term potential for commercialization. As we continue our preparations for success in treating both acute and chronic illnesses through advanced product offerings, we believe Tom’s extensive experience and expertise will be invaluable. We have had the pleasure of working with Tom since 2020 and during that time he has, among other things, ensured that our business objectives and agency regulations were met. As we continue to progress, we are pleased to welcome him as VP, Operations and Product Development, and look forward to continuing to leverage the leadership and skills he has amassed over the course of his career,” commented Eric Schlorff, Chief Executive Officer of SeaStar Medical. Since 1993, Mr. Mullen has led Mullen Business Development, a manufacturing, engineering and operations consulting firm. Since its founding, he has served as a consultant to several medical device organizations from startup to Fortune 500 to establish and execute strategies, budgets and plans, as well as develop products, processes and operational systems. Mr. Mullen has served as a consultant to SeaStar Medical since 2020, during which time he oversaw contract manufacturing activities, assisted with agency submissions and provided remediation of compliance documentation. During his consulting career, Mr. Mullen has managed the relocation of multiple manufacturing lines from the U.S. to Mexico, completed successful external ISO and FDA audits, and has written and sourced compliance documentation for product development and design control. Prior to his consultancy with SeaStar Medical, he oversaw the manufacturing, engineering, and project management for an implantable tissue heart patch, qualification of ...